Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Villin 1 antibody (AA 1-188)

Cited in 1 publication. The Mouse Monoclonal anti-Villin 1 antibody (Clone OTI3B3) (ABIN2735261) specifically detects Villin 1 in WB. The antibody is reactive with Human samples.
Catalog No. ABIN2735261
$608.40
Plus shipping costs $50.00
0.1 mL
Shipping to: United States
Delivery in 6 to 8 Business Days

Quick Overview for Villin 1 antibody (AA 1-188) (ABIN2735261)

Target

See all Villin 1 (VIL1) Antibodies
Villin 1 (VIL1)

Reactivity

  • 122
  • 34
  • 30
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human

Host

  • 76
  • 46
Mouse

Clonality

  • 83
  • 39
Monoclonal

Conjugate

  • 51
  • 9
  • 5
  • 5
  • 5
  • 5
  • 5
  • 5
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 4
  • 2
  • 2
This Villin 1 antibody is un-conjugated

Application

  • 65
  • 64
  • 30
  • 27
  • 18
  • 14
  • 12
  • 7
  • 4
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB)

Clone

OTI3B3
  • Binding Specificity

    • 45
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 1-188

    Purification

    Purified from mouse ascites fluids by affinity chromatography

    Immunogen

    Human recombinant protein fragment corresponding to amino acids 1-188 of human VIL1 (NP_009058) produced in E.coli.

    Isotype

    IgG1
  • Application Notes

    WB 1:2000,

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    1 mg/mL
  • Li, Zhu, Liu, Yu, Chen, Dong, Gong, Yuan: "HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach." in: Scientific reports, Vol. 7, Issue 1, pp. 2278, (2019) (PubMed).

  • Target

    Villin 1 (VIL1)

    Alternative Name

    VIL1

    Molecular Weight

    92.5 kDa

    NCBI Accession

    NM_007127

    HGNC

    7429

    Pathways

    EGFR Signaling Pathway, Regulation of Actin Filament Polymerization
You are here:
Chat with us!